Search

Your search keyword '"Molina, J-M"' showing total 1,089 results

Search Constraints

Start Over You searched for: Author "Molina, J-M" Remove constraint Author: "Molina, J-M"
1,089 results on '"Molina, J-M"'

Search Results

1. Developing Enhanced Conversational Agents for Social Virtual Worlds

2. X-ray imaging and electron temperature evolution in laser-driven magnetic reconnection experiments at the National Ignition Facility

3. Agent-based Simulation with Netlogo to Evaluate AmI Scenarios

4. Trust model of privacy-concerned, emotionally-aware agents in a cooperative logistics problem

7. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France

8. A Molecular Dynamics Study of Laser-Excited Gold

10. Reactive infiltration: identifying the role of chemical reactions, capillarity, viscosity and gravity

11. Isoniazid-monoresistant tuberculosis in France: Risk factors, treatment outcomes and adverse events

12. Outcomes of patients hospitalized in ward settings for COVID-19 pneumonia with or without early empirical antibiotics.

14. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

15. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies

16. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

17. Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

24. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

29. A Legal View of Ambient Assisted Living Developments

30. Segmentation and Classification of Time-Series: Real Case Studies

31. Context Data to Improve Association in Visual Tracking Systems

32. Set of Methods for Spontaneous ICH Segmentation and Tracking from CT Head Images

33. Evolutionary Computation Technique Applied to HSPF Model Calibration of a Spanish Watershed

34. Improving the Segmentation Stage of a Pedestrian Tracking Video-Based System by Means of Evolution Strategies

35. Correction to: Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study

37. Efficacy and safety of long-acting subcutaneous lenacapavir in phase 2/3 in heavily treatment-experienced people with HIV: week 26 results (Capella study)

40. Perception of PrEP‐related stigma in PrEP users: Results from the ANRS‐PREVENIR cohort.

43. Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study

44. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

49. Design of Replicated Open-Pore Aluminium Cellular Materials with a Non-Stochastic Structure for Sound Absorption Applications

Catalog

Books, media, physical & digital resources